Fluorine in PDB 4pnz: Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Enzymatic activity of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
All present enzymatic activity of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102):
3.4.14.5;
Protein crystallography data
The structure of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102), PDB code: 4pnz
was solved by
G.Scapin,
Y.Yan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.15 /
1.90
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
117.940,
125.777,
137.085,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.6 /
19.7
|
Other elements in 4pnz:
The structure of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
(pdb code 4pnz). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102), PDB code: 4pnz:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 1 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F802
b:22.3
occ:1.00
|
F2
|
A:2VH802
|
0.0
|
22.3
|
1.0
|
C
|
A:2VH802
|
1.4
|
21.4
|
1.0
|
C5
|
A:2VH802
|
2.3
|
20.8
|
1.0
|
C1
|
A:2VH802
|
2.4
|
18.0
|
1.0
|
F
|
A:2VH802
|
2.7
|
22.0
|
1.0
|
CG2
|
A:VAL656
|
3.1
|
14.0
|
1.0
|
CG2
|
A:VAL711
|
3.2
|
14.6
|
1.0
|
OG
|
A:SER630
|
3.4
|
26.2
|
1.0
|
C2
|
A:2VH802
|
3.6
|
17.7
|
1.0
|
C4
|
A:2VH802
|
3.6
|
18.1
|
1.0
|
N
|
A:TYR631
|
3.8
|
13.0
|
1.0
|
C
|
A:SER630
|
4.0
|
16.5
|
1.0
|
CE1
|
A:TYR662
|
4.1
|
14.8
|
1.0
|
C3
|
A:2VH802
|
4.1
|
19.4
|
1.0
|
CZ
|
A:TYR662
|
4.2
|
16.0
|
1.0
|
CB
|
A:VAL656
|
4.3
|
14.8
|
1.0
|
CA
|
A:SER630
|
4.3
|
13.5
|
1.0
|
CB
|
A:SER630
|
4.4
|
17.3
|
1.0
|
CA
|
A:TYR631
|
4.4
|
13.5
|
1.0
|
OH
|
A:TYR662
|
4.4
|
16.0
|
1.0
|
CD1
|
A:TYR662
|
4.5
|
15.9
|
1.0
|
O
|
A:SER630
|
4.5
|
16.6
|
1.0
|
CB
|
A:VAL711
|
4.6
|
14.7
|
1.0
|
CE2
|
A:TYR662
|
4.6
|
15.0
|
1.0
|
NE2
|
A:HIS740
|
4.7
|
17.7
|
1.0
|
F1
|
A:2VH802
|
4.7
|
18.6
|
1.0
|
N
|
A:VAL656
|
4.8
|
12.1
|
1.0
|
CE1
|
A:HIS740
|
4.8
|
17.5
|
1.0
|
CG
|
A:TYR662
|
4.9
|
14.4
|
1.0
|
CG1
|
A:VAL711
|
4.9
|
13.7
|
1.0
|
CB
|
A:TYR631
|
4.9
|
14.0
|
1.0
|
CD2
|
A:TYR662
|
4.9
|
14.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 2 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F802
b:22.0
occ:1.00
|
F
|
A:2VH802
|
0.0
|
22.0
|
1.0
|
C5
|
A:2VH802
|
1.4
|
20.8
|
1.0
|
C
|
A:2VH802
|
2.3
|
21.4
|
1.0
|
C4
|
A:2VH802
|
2.4
|
18.1
|
1.0
|
F2
|
A:2VH802
|
2.7
|
22.3
|
1.0
|
CD2
|
A:TYR631
|
3.4
|
14.3
|
1.0
|
CE1
|
A:TYR666
|
3.5
|
16.5
|
1.0
|
OH
|
A:TYR666
|
3.6
|
17.2
|
1.0
|
C1
|
A:2VH802
|
3.6
|
18.0
|
1.0
|
C3
|
A:2VH802
|
3.6
|
19.4
|
1.0
|
CB
|
A:TYR631
|
3.7
|
14.0
|
1.0
|
CZ
|
A:TYR666
|
3.7
|
18.7
|
1.0
|
CH2
|
A:TRP659
|
3.9
|
16.2
|
1.0
|
CG
|
A:TYR631
|
4.0
|
15.0
|
1.0
|
CA
|
A:TYR631
|
4.0
|
13.5
|
1.0
|
C2
|
A:2VH802
|
4.0
|
17.7
|
1.0
|
N
|
A:TYR631
|
4.1
|
13.0
|
1.0
|
CZ3
|
A:TRP659
|
4.3
|
15.8
|
1.0
|
CE2
|
A:TYR662
|
4.3
|
15.0
|
1.0
|
CD1
|
A:TYR666
|
4.3
|
16.8
|
1.0
|
CG2
|
A:VAL656
|
4.4
|
14.0
|
1.0
|
CE2
|
A:TYR631
|
4.4
|
15.7
|
1.0
|
OG
|
A:SER630
|
4.6
|
26.2
|
1.0
|
CE2
|
A:TYR666
|
4.6
|
15.8
|
1.0
|
CZ
|
A:TYR662
|
4.6
|
16.0
|
1.0
|
OH
|
A:TYR547
|
4.7
|
25.5
|
1.0
|
CD2
|
A:TYR662
|
4.7
|
14.7
|
1.0
|
O
|
A:HOH1082
|
4.8
|
28.1
|
1.0
|
OH
|
A:TYR662
|
4.9
|
16.0
|
1.0
|
C6
|
A:2VH802
|
4.9
|
19.4
|
1.0
|
C
|
A:SER630
|
5.0
|
16.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 3 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F802
b:18.6
occ:1.00
|
F1
|
A:2VH802
|
0.0
|
18.6
|
1.0
|
C2
|
A:2VH802
|
1.3
|
17.7
|
1.0
|
C1
|
A:2VH802
|
2.3
|
18.0
|
1.0
|
C3
|
A:2VH802
|
2.3
|
19.4
|
1.0
|
C6
|
A:2VH802
|
2.8
|
19.4
|
1.0
|
NH2
|
A:ARG125
|
3.1
|
19.2
|
1.0
|
ND2
|
A:ASN710
|
3.2
|
14.9
|
1.0
|
OE2
|
A:GLU205
|
3.4
|
16.2
|
1.0
|
N
|
A:2VH802
|
3.5
|
16.9
|
1.0
|
OH
|
A:TYR662
|
3.5
|
16.0
|
1.0
|
O
|
A:HOH1101
|
3.6
|
30.5
|
1.0
|
C
|
A:2VH802
|
3.6
|
21.4
|
1.0
|
C4
|
A:2VH802
|
3.6
|
18.1
|
1.0
|
OD1
|
A:ASN710
|
3.6
|
17.8
|
1.0
|
CG
|
A:ASN710
|
3.7
|
19.1
|
1.0
|
O
|
A:HOH978
|
3.7
|
24.7
|
1.0
|
C10
|
A:2VH802
|
3.7
|
17.4
|
1.0
|
CD2
|
A:HIS740
|
3.8
|
18.7
|
1.0
|
NE2
|
A:HIS740
|
3.8
|
17.7
|
1.0
|
OG
|
A:SER630
|
3.9
|
26.2
|
1.0
|
O
|
A:2VH802
|
3.9
|
22.3
|
1.0
|
C5
|
A:2VH802
|
4.0
|
20.8
|
1.0
|
CZ
|
A:ARG125
|
4.5
|
30.8
|
1.0
|
CD
|
A:GLU205
|
4.6
|
22.5
|
1.0
|
F2
|
A:2VH802
|
4.7
|
22.3
|
1.0
|
CZ
|
A:TYR662
|
4.7
|
16.0
|
1.0
|
C9
|
A:2VH802
|
4.8
|
19.5
|
1.0
|
C7
|
A:2VH802
|
4.8
|
18.9
|
1.0
|
CG
|
A:HIS740
|
4.8
|
16.3
|
1.0
|
CE1
|
A:HIS740
|
4.9
|
17.5
|
1.0
|
CB
|
A:ASN710
|
4.9
|
11.4
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 4 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:21.5
occ:1.00
|
F2
|
B:2VH801
|
0.0
|
21.5
|
1.0
|
C
|
B:2VH801
|
1.3
|
21.6
|
1.0
|
C5
|
B:2VH801
|
2.3
|
23.3
|
1.0
|
C1
|
B:2VH801
|
2.4
|
19.6
|
1.0
|
F
|
B:2VH801
|
2.7
|
21.1
|
1.0
|
CG2
|
B:VAL656
|
3.0
|
15.6
|
1.0
|
CG2
|
B:VAL711
|
3.1
|
14.2
|
1.0
|
OG
|
B:SER630
|
3.4
|
28.2
|
1.0
|
C2
|
B:2VH801
|
3.6
|
21.6
|
1.0
|
C4
|
B:2VH801
|
3.6
|
22.4
|
1.0
|
N
|
B:TYR631
|
3.9
|
17.3
|
1.0
|
C
|
B:SER630
|
4.1
|
20.2
|
1.0
|
CZ
|
B:TYR662
|
4.1
|
16.7
|
1.0
|
CE1
|
B:TYR662
|
4.1
|
15.1
|
1.0
|
C3
|
B:2VH801
|
4.1
|
20.9
|
1.0
|
CB
|
B:VAL656
|
4.3
|
16.1
|
1.0
|
CA
|
B:SER630
|
4.4
|
17.8
|
1.0
|
OH
|
B:TYR662
|
4.4
|
17.3
|
1.0
|
CB
|
B:SER630
|
4.4
|
19.6
|
1.0
|
CD1
|
B:TYR662
|
4.5
|
15.8
|
1.0
|
CA
|
B:TYR631
|
4.5
|
16.3
|
1.0
|
CE2
|
B:TYR662
|
4.5
|
16.4
|
1.0
|
CB
|
B:VAL711
|
4.6
|
14.3
|
1.0
|
O
|
B:SER630
|
4.6
|
18.3
|
1.0
|
NE2
|
B:HIS740
|
4.7
|
18.9
|
1.0
|
F1
|
B:2VH801
|
4.7
|
20.1
|
1.0
|
CE1
|
B:HIS740
|
4.8
|
18.8
|
1.0
|
N
|
B:VAL656
|
4.8
|
14.6
|
1.0
|
CG
|
B:TYR662
|
4.9
|
14.4
|
1.0
|
CD2
|
B:TYR662
|
4.9
|
15.7
|
1.0
|
CG1
|
B:VAL711
|
5.0
|
13.2
|
1.0
|
CB
|
B:TYR631
|
5.0
|
16.3
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 5 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:21.1
occ:1.00
|
F
|
B:2VH801
|
0.0
|
21.1
|
1.0
|
C5
|
B:2VH801
|
1.3
|
23.3
|
1.0
|
C
|
B:2VH801
|
2.3
|
21.6
|
1.0
|
C4
|
B:2VH801
|
2.3
|
22.4
|
1.0
|
F2
|
B:2VH801
|
2.7
|
21.5
|
1.0
|
CD2
|
B:TYR631
|
3.3
|
16.6
|
1.0
|
OH
|
B:TYR666
|
3.5
|
23.2
|
1.0
|
CE1
|
B:TYR666
|
3.6
|
21.1
|
1.0
|
C1
|
B:2VH801
|
3.6
|
19.6
|
1.0
|
C3
|
B:2VH801
|
3.6
|
20.9
|
1.0
|
CZ
|
B:TYR666
|
3.7
|
22.5
|
1.0
|
CB
|
B:TYR631
|
3.7
|
16.3
|
1.0
|
CG
|
B:TYR631
|
4.0
|
16.5
|
1.0
|
CH2
|
B:TRP659
|
4.0
|
17.5
|
1.0
|
C2
|
B:2VH801
|
4.0
|
21.6
|
1.0
|
CA
|
B:TYR631
|
4.1
|
16.3
|
1.0
|
N
|
B:TYR631
|
4.1
|
17.3
|
1.0
|
CD1
|
B:TYR666
|
4.4
|
18.3
|
1.0
|
CE2
|
B:TYR631
|
4.4
|
16.1
|
1.0
|
CZ3
|
B:TRP659
|
4.4
|
17.2
|
1.0
|
CE2
|
B:TYR662
|
4.4
|
16.4
|
1.0
|
CG2
|
B:VAL656
|
4.4
|
15.6
|
1.0
|
OG
|
B:SER630
|
4.5
|
28.2
|
1.0
|
OH
|
B:TYR547
|
4.5
|
28.3
|
1.0
|
CE2
|
B:TYR666
|
4.6
|
17.1
|
1.0
|
CZ
|
B:TYR662
|
4.7
|
16.7
|
1.0
|
O
|
B:HOH1022
|
4.7
|
30.2
|
1.0
|
CD2
|
B:TYR662
|
4.8
|
15.7
|
1.0
|
C6
|
B:2VH801
|
4.9
|
17.7
|
1.0
|
OH
|
B:TYR662
|
4.9
|
17.3
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 4pnz
Go back to
Fluorine Binding Sites List in 4pnz
Fluorine binding site 6 out
of 6 in the Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human Dipeptidyl Peptidase IV/CD26 in Complex with the Long-Acting Inhibitor Omarigliptin (Mk-3102) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:20.1
occ:1.00
|
F1
|
B:2VH801
|
0.0
|
20.1
|
1.0
|
C2
|
B:2VH801
|
1.4
|
21.6
|
1.0
|
C1
|
B:2VH801
|
2.3
|
19.6
|
1.0
|
C3
|
B:2VH801
|
2.4
|
20.9
|
1.0
|
C6
|
B:2VH801
|
2.8
|
17.7
|
1.0
|
ND2
|
B:ASN710
|
3.2
|
14.8
|
1.0
|
NH2
|
B:ARG125
|
3.2
|
23.0
|
1.0
|
OE2
|
B:GLU205
|
3.4
|
19.3
|
1.0
|
OD1
|
B:ASN710
|
3.4
|
18.4
|
1.0
|
N
|
B:2VH801
|
3.5
|
17.8
|
1.0
|
O
|
B:HOH1108
|
3.5
|
32.7
|
1.0
|
OH
|
B:TYR662
|
3.5
|
17.3
|
1.0
|
CG
|
B:ASN710
|
3.6
|
20.6
|
1.0
|
C
|
B:2VH801
|
3.6
|
21.6
|
1.0
|
C4
|
B:2VH801
|
3.6
|
22.4
|
1.0
|
C10
|
B:2VH801
|
3.7
|
17.7
|
1.0
|
CD2
|
B:HIS740
|
3.8
|
19.2
|
1.0
|
O
|
B:HOH1008
|
3.9
|
22.6
|
1.0
|
NE2
|
B:HIS740
|
3.9
|
18.9
|
1.0
|
O
|
B:2VH801
|
4.0
|
20.1
|
1.0
|
OG
|
B:SER630
|
4.0
|
28.2
|
1.0
|
C5
|
B:2VH801
|
4.1
|
23.3
|
1.0
|
CD
|
B:GLU205
|
4.5
|
24.8
|
1.0
|
CZ
|
B:ARG125
|
4.5
|
37.0
|
1.0
|
O
|
B:HOH1619
|
4.5
|
48.0
|
1.0
|
CZ
|
B:TYR662
|
4.6
|
16.7
|
1.0
|
F2
|
B:2VH801
|
4.7
|
21.5
|
1.0
|
C9
|
B:2VH801
|
4.7
|
17.7
|
1.0
|
CB
|
B:ASN710
|
4.8
|
13.9
|
1.0
|
CG
|
B:HIS740
|
4.8
|
17.4
|
1.0
|
C7
|
B:2VH801
|
4.8
|
18.7
|
1.0
|
CE1
|
B:HIS740
|
4.9
|
18.8
|
1.0
|
|
Reference:
T.Biftu,
R.Sinha-Roy,
P.Chen,
X.Qian,
D.Feng,
J.T.Kuethe,
G.Scapin,
Y.D.Gao,
Y.Yan,
D.Krueger,
A.Bak,
G.Eiermann,
J.He,
J.Cox,
J.Hicks,
K.Lyons,
H.He,
G.Salituro,
S.Tong,
S.Patel,
G.Doss,
A.Petrov,
J.Wu,
S.S.Xu,
C.Sewall,
X.Zhang,
B.Zhang,
N.A.Thornberry,
A.E.Weber.
Omarigliptin (Mk-3102): A Novel Long-Acting Dpp-4 Inhibitor For Once-Weekly Treatment of Type 2 Diabetes. J.Med.Chem. V. 57 3205 2014.
ISSN: ISSN 0022-2623
PubMed: 24660890
DOI: 10.1021/JM401992E
Page generated: Thu Aug 1 04:56:01 2024
|